Highly uniform particle size distribution for excellent flowability and compressibility in direct compression tablet formulations.
Optimized crystallinity and surface morphology to enhance binding strength and tablet hardness without excessive binder addition.
Low moisture content (< 5.0%) ensuring superior chemical stability and extended shelf life of final dosage forms.
Pharmaceutical-grade purity compliant with USP/NF, EP, and JP monographs for microcrystalline cellulose.
Consistent lot-to-lot performance validated through rigorous in-process and release testing per ICH Q5 and Q7 guidelines.
Direct compression excipient in oral solid dosage forms, including immediate-release and modified-release tablets.
Tablet binder and disintegrant in combination with low-dose potent APIs requiring high dilution capacity.
Stabilizer and bulking agent in lyophilized biopharmaceutical formulations and diagnostic reagent tablets.
Functional filler in chewable tablets and orally disintegrating tablets (ODTs) due to neutral taste and smooth mouthfeel.
Carrier matrix in dry powder inhalers (DPIs) leveraging its controlled particle engineering and aerosolization efficiency.
| Chemical Type | Microcrystalline cellulose (MCC) |
| Product Form | Free-flowing white to off-white granular powder |
| Appearance | Odorless, tasteless, fine granules |
| Primary Applications | Pharmaceutical direct compression, tablet binding, and pharmaceutical excipient |
| Key Features | High compressibility, excellent flowability, low moisture content |
| Compliance | USP/NF, EP 10.0, JP 18, FDA GRAS affirmed |
| Storage Conditions | Store in original sealed container at 15–25°C, relative humidity < 60% |
| Shelf Life | 36 months from date of manufacture when stored under recommended conditions |
Contact With Us:
E-mail: wangxingqiang@ericwchem.com
Have a Questions? Call Us:
Add:
Building A1, Jiete Industrial Park, Huangpu District, Guangzhou City, Guangdong Province, China